<SEC-DOCUMENT>0001062993-15-005314.txt : 20151007
<SEC-HEADER>0001062993-15-005314.hdr.sgml : 20151007
<ACCEPTANCE-DATETIME>20151007061459
ACCESSION NUMBER:		0001062993-15-005314
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20151007
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151007
DATE AS OF CHANGE:		20151007

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXARIA CORP.
		CENTRAL INDEX KEY:			0001348362
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		IRS NUMBER:				202000871
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52138
		FILM NUMBER:		151147686

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 950, 1130 WEST PENDER STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 4A4
		BUSINESS PHONE:		604-602-1675

	MAIL ADDRESS:	
		STREET 1:		SUITE 950, 1130 WEST PENDER STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 4A4

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lexaria Corp.
		DATE OF NAME CHANGE:	20051229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
   <TITLE>Lexaria Corp.: Form 8-K - Filed by newsfilecorp.com</TITLE>
   <META name="HandheldFriendly" content="true">
</HEAD>

<BODY style="font-size:10pt;">

<HR noshade align="center" width=100% size=3 color="black">
<A name=page_1></A>
<P align=center><B><FONT size=5>UNITED STATES </FONT><BR></B><B><FONT
size=5>SECURITIES AND EXCHANGE COMMISSION </FONT><BR>Washington, D.C. 20549
</B></P>
<P align=center><B><FONT size=5>FORM 8-K </FONT></B></P>
<P align=center>Current Report <BR>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 </P>
<DIV>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
borderColor=#000000 cellSpacing=0 cellPadding=3 width="100%" border=1>

  <TR vAlign=top>
    <TD align=center colSpan=3>Date of Report (date of earliest event
      reported): October 7, 2015 </TD></TR>
  <TR vAlign=bottom>
    <TD align=center colSpan=3 rowSpan=2><B><FONT size=5>LEXARIA CORP.
      </FONT></B><BR>(Exact name of registrant as specified in its charter)
  </TD></TR>
  <TR vAlign=bottom></TR>
  <TR vAlign=top>
    <TD align=center rowSpan=3>Nevada <BR>(State or other jurisdiction of
      <BR>incorporation) </TD>
    <TD align=center width="33%" rowSpan=3>000-52138 <BR>(Commission File
      Number) </TD>
    <TD align=center width="33%" rowSpan=3>20-2000871 <BR>(IRS Employer
      Identification No.) </TD></TR>
  <TR vAlign=top></TR>
  <TR vAlign=top></TR>
  <TR vAlign=top>
    <TD align=center colSpan=3>#950 &#150; 1130 West Pender Street, Vancouver,
      British Columbia, Canada V6E 4A4 </TD></TR>
  <TR vAlign=top>
    <TD align=center colSpan=3>Registrant's telephone number, including area
      code: (604) 602-1675 </TD></TR>
  <TR vAlign=bottom>
    <TD align=center colSpan=3>(Former name or former address, if changed
      since last report.) </TD></TR></TABLE></DIV>
<P align=justify>Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions: </P>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD align=left >[&nbsp;&nbsp; ]</TD>
    <TD align=left width="95%">Written communications pursuant to Rule 425
      under the Securities Act (17 CFR 230.425) </TD></TR>
  <TR>
    <TD align=left  >&nbsp;</TD>
    <TD align=left width="95%" >&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=left >[&nbsp;&nbsp; ]</TD>
    <TD align=left width="95%">Soliciting material pursuant to Rule 14a-12
      under the Exchange Act (17 CFR 240.14a-12) </TD></TR>
  <TR>
    <TD align=left  >&nbsp;</TD>
    <TD align=left width="95%" >&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=left >[&nbsp;&nbsp; ]</TD>
    <TD align=left width="95%">Pre-commencement communications pursuant to
      Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b)) </TD></TR>
  <TR>
    <TD align=left  >&nbsp;</TD>
    <TD align=left width="95%" >&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=left >[&nbsp;&nbsp; ]</TD>
    <TD align=left width="95%">Pre-commencement communications pursuant to
      Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
</TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_2></A><BR>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD align=left ><B>Item 7.01 </B></TD>
    <TD align=left width="90%" ><STRONG>Regulation FD
      Disclosure.</STRONG> </TD></TR></TABLE>
<P align=justify>A copy of the news release announcing Lexaria to Present on
Cannabis Investor Webcast filed as exhibit 99.1 to this current report and is
hereby incorporated by reference. </P>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD align=left ><B>ITEM 9.01. </B></TD>
    <TD align=left width="90%" ><STRONG>FINANCIAL STATEMENTS AND
      EXHIBITS.</STRONG> </TD></TR></TABLE><BR>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD align=center ><B>Exhibit No.</B> </TD>
    <TD align=center width="90%"><B>Description</B> </TD></TR>
  <TR vAlign=top>
    <TD align=center bgColor=#eeeeee ><A
      href="exhibit99-1.htm">99.1 </A></TD>
    <TD align=center width="90%" bgColor=#eeeeee><A
      href="exhibit99-1.htm">News Release dated October 7,
      2015 </A></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_3></A>
<P align=center><B>SIGNATURES </B></P>
<P align=justify>Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P>
<P align=justify>Dated: October 7, 2015 </P>
<DIV>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=top>
    <TD align=left >&nbsp; </TD>
    <TD align=left width="80%">Lexaria Corp. </TD></TR>
  <TR vAlign=top>
    <TD align=left >(Signature) </TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left width="80%">By:
      &#147;<I>/s/ Chris Bunka&#148;</I> </TD></TR>
  <TR vAlign=top>
    <TD align=left >&nbsp; </TD>
    <TD align=left width="80%">Chris Bunka </TD></TR>
  <TR vAlign=top>
    <TD align=left >&nbsp; </TD>
    <TD align=left width="80%">President &amp; CEO
</TD></TR></TABLE></DIV><BR>
<HR align=center width="100%" color=black noShade SIZE=5>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
   <TITLE>Lexaria Corp.: Exhibit 99.1 - Filed by newsfilecorp.com</TITLE>
   <META name="HandheldFriendly" content="true">
</HEAD>

<BODY style="font-size:10pt;">

<HR noshade align="center" width=100% size=3 color="black">
<!--$$/page=--><A name=page_1></A>
<P align=center><B>Lexaria, Corp. to Present on Cannabis Investor Webcast
Tomorrow </B></P>
<P align=justify>Kelowna, BC / October 7, 2015 / Lexaria, Corp. (LXRP) (CSE:
LXX) a food sciences company is pleased to announce that John Docherty,
President will be presenting on the Cannabis Investor Webcast
(<U>www.cannawebcast.com</U>) on Thursday, October 8, 2015 at 5:00 PM EDT (2:00
PM PDT).</P>
<P align=justify>"We're delighted to welcome back Lexaria<STRIKE>,</STRIKE>
Corp. to present to our online audience of investors, analysts, entrepreneurs,
media, and consumers," said Derwin A. Wallace, Founder of Cannabis Investor
Webcast. &#147;Our audience is eager to see industry companies that have solid
business models and that are generating revenues.&#148; </P>
<P align=justify>The Cannabis Investor Webcast includes presentations from
privately-held and publicly-traded industry companies and industry
professionals. Lexaria, Corp&#146;s LIVE presentation will be 30-minutes long,
followed by 15-minutes of real-time Q&amp;A. The Cannabis Investor Webcast is a
great opportunity for the audience to research Lexaria, Corp. without taking
time-off from work, paying registration fees or incurring travel-related
expenses. </P>
<P align=justify>"Lexaria, Corp. presented on the Cannabis Investor Webcast in
March, since then we have reached some major milestones," said John Docherty,
President of Lexaria Corp. &#147;Our presentation will give us an opportunity to
update the audience on recent developments, like our new protein energy bar. In
addition, we will give an overview of our technology and our team.&#148; </P>
<P align=justify>Investors, analysts, entrepreneurs, media, and consumers who
want to learn more about our ViPova-brand Tea, or Lexaria Energy nutrition
products, can attend the free online webcast by clicking on the link
<U>http://www.cannawebcast.com</U> and visit the Registration Page. To view the
recording of the webcast please click on this link <U>www.youtube.com</U> two
weeks after the presentation and search for Cannabis Investor Webcast. </P>
<P align=justify><B>About Lexaria, Corp. </B></P>
<P align=justify>Lexaria, Corp. is a food sciences company focused on the
delivery of hemp oil compounds procured from legal, agricultural hemp seed oil,
through gourmet foods products based upon its proprietary infusion technologies.
Lexaria Corp. is focused on your comfort and well-being. Lexaria Corp&#146;s common
shares are quoted in the USA with the symbol LXRP and in Canada with the symbol
LXX. The company searches for projects that could provide potential above-market
shareholder value. To learn more about Lexaria Corp. please visit
www.lexariaenergy.com.</P>
<P align=justify>FOR FURTHER INFORMATION PLEASE CONTACT:</P>
<P align=justify>Lexaria Corp. <BR>Chris Bunka<BR>Chairman &amp; CEO <BR>(250) 765-6424</P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_2></A>
<P align=justify>FORWARD-LOOKING STATEMENTS </P>
<P align=justify>This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements, including but not limited to: the
launching of the new Lexaria Energy10 bar on or near November 3, 2015. Such
forward-looking statements are estimates reflecting the Company's best judgment
based upon current information and involve a number of risks and uncertainties,
and there can be no assurance that other factors will not affect the accuracy of
such forward-looking statements. Access to capital, or lack thereof, is a major
risk and there is no assurance that the Company will be able to raise required
working capital. Factors which could cause actual results to differ materially
from those estimated by the Company include, but are not limited to, government
regulation, managing and maintaining growth, the effect of adverse publicity,
litigation, competition, the patent application and approval process and other
factors which may be identified from time to time in the Company's public
announcements and filings. There is no assurance that the medical marijuana,
hemp oil sector, or alternative health businesses will provide any benefit to
Lexaria, or that the Company will experience any growth through participation in
these sectors. There is no assurance that existing capital is sufficient for the
Company's needs or that it will not need to attempt to raise additional capital.
There is no assurance that any planned corporate activity, business venture, or
initiative will be pursued, or if pursued, will be successful. There is no
assurance that any hemp oil or cannabinoid-based product will promote, assist,
or maintain any beneficial human health conditions whatsoever. There is no
assurance that the cannabinoid/lipid infusion technology will provide any
increase in bioavailability to any individual person. There is no assurance that
any patent application in the USA or any other nation or under any treaty will
result in the award of an actual patent; nor that an award of any actual patent
will protect against challenges from unknown third parties. There is no
assurance that any of Lexaria&#146;s postulated uses, benefits, or advantages for the
patent-pending technology will in fact be realized in any manner or in any part.
No statement herein has been evaluated by the Food and Drug Administration
(FDA). ViPova<SUP>TM</SUP> products and Lexaria Energy products are not intended
to diagnose, treat, cure or prevent any disease.</P>
<P align=justify><I>The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.</I><I> </I></P>
<HR align=center width="100%" color=black noShade SIZE=5>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
